Our Companies

Related Sciences builds, invests in, and manages a unique class of risk-optimized biotech companies called "Constellations", each constructed around a large, data-driven portfolio of the very best opportunities in an ascendant area of commercial interest, and leveraging a novel architecture designed to significantly improve its efficiency and odds of successful value creation.

RS Constellation I

Launched 2021

Danger Bio focuses on danger detection—the “alarm system” inside of every cell which alerts the immune system to threats like infection and injury, and when imbalanced, can drive autoimmunity or cancers

RS Constellation II

Coming Soon

Currently in design and assembly phase. Research focus not yet disclosed.